Tempus Wealth Planning LLC Purchases 141 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Tempus Wealth Planning LLC boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.5% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 30,892 shares of the company’s stock after buying an additional 141 shares during the period. GE HealthCare Technologies makes up about 1.0% of Tempus Wealth Planning LLC’s investment portfolio, making the stock its 21st biggest position. Tempus Wealth Planning LLC’s holdings in GE HealthCare Technologies were worth $2,407,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Independence Bank of Kentucky increased its stake in shares of GE HealthCare Technologies by 75.8% in the 2nd quarter. Independence Bank of Kentucky now owns 1,624 shares of the company’s stock valued at $127,000 after acquiring an additional 700 shares during the last quarter. Family Firm Inc. acquired a new stake in GE HealthCare Technologies in the second quarter worth $37,000. Avitas Wealth Management LLC acquired a new stake in GE HealthCare Technologies in the second quarter worth $1,517,000. Cultivar Capital Inc. acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at $62,000. Finally, GYL Financial Synergies LLC increased its position in shares of GE HealthCare Technologies by 7.6% in the 2nd quarter. GYL Financial Synergies LLC now owns 125,897 shares of the company’s stock valued at $9,810,000 after buying an additional 8,865 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Ratings Changes

GEHC has been the topic of several recent analyst reports. The Goldman Sachs Group began coverage on GE HealthCare Technologies in a report on Thursday, May 30th. They set a “neutral” rating and a $87.00 target price on the stock. Bank of America reduced their price target on shares of GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating for the company in a report on Wednesday, May 1st. Stifel Nicolaus started coverage on GE HealthCare Technologies in a report on Tuesday, August 6th. They issued a “buy” rating and a $100.00 price target on the stock. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Finally, Mizuho reduced their price target on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research report on Wednesday, May 1st. Five equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $95.00.

Insiders Place Their Bets

In other news, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the transaction, the chief executive officer now owns 17,509 shares of the company’s stock, valued at approximately $1,414,377.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other GE HealthCare Technologies news, CTO Taha Kass-Hout sold 3,300 shares of the company’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total value of $259,710.00. Following the completion of the transaction, the chief technology officer now owns 67,300 shares of the company’s stock, valued at approximately $5,296,510. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Thomas J. Westrick sold 2,750 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the sale, the chief executive officer now directly owns 17,509 shares in the company, valued at $1,414,377.02. The disclosure for this sale can be found here. Corporate insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC traded up $0.41 during mid-day trading on Friday, reaching $84.78. 1,511,760 shares of the company’s stock were exchanged, compared to its average volume of 3,015,838. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.83 and a current ratio of 1.06. The firm has a market capitalization of $38.70 billion, a PE ratio of 24.79, a price-to-earnings-growth ratio of 3.00 and a beta of 1.17. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.50. The business’s fifty day simple moving average is $80.77 and its two-hundred day simple moving average is $83.41.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, topping the consensus estimate of $0.98 by $0.02. The company had revenue of $4.84 billion for the quarter, compared to analysts’ expectations of $4.88 billion. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The business’s revenue for the quarter was up .5% on a year-over-year basis. During the same period last year, the firm earned $0.92 earnings per share. Analysts anticipate that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were given a dividend of $0.03 per share. The ex-dividend date of this dividend was Friday, July 19th. This represents a $0.12 annualized dividend and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.